BioCentury
ARTICLE | Clinical News

GTx begins Phase prostate cancer IIb/III

October 23, 2001 7:00 AM UTC

GTx (Memphis, Tenn.) began a double-blind, placebo-controlled U.S. Phase IIb/III trial of its Acapodene toremifene non-steroidal antiestrogen to prevent prostate cancer. The study in 500 patients with...